Staff Data Platform Engineer: OLAP & ClickHouse

Genomics plc; Greater London, Oxford; Híbrido; GBP 140 000 - 190 000; Tempo integral

Vantagens oferecidas por esta oferta de emprego

Life insurance

Charities trust

Pension

Group income protection

Cycle to work scheme

Critical illness cover

Private medical cover

Bank your Bank Holidays

Social events

Training and development opportunities

Organised sports activities

Resumo da oferta

Genomics plc in London (Hybrid) seeks a Staff-level data platform engineer to own Mystra’s data foundations and our Data-as-a-Service offering. You’ll shape multi-tenant analytics, drive secure, scalable architecture, and mentor engineers while collaborating with the ML team.

Responsibilities include designing resilient storage and release strategies, ensuring data products are discoverable at scale, and enabling agent-ready AI capabilities for drug discovery.

Qualificações

• Experience with large-scale analytical platforms and multi-tenant data systems.
• Proven ability to design secure, scalable data architectures and releases.
• Strong leadership and mentoring capabilities for engineering teams.

Responsabilidades

• Own Mystra data foundations and the Data-as-a-Service offering.
• Shape multi-tenant analytics and secure architecture at scale.
• Mentor engineers and collaborate with ML teams on AI workflows.
• Drive performance, reliability, and data discoverability at petabyte scale.

Conhecimentos

ClickHouse OLAP

Platform engineering

Data as a service

Tenant isolation security

Technical leadership

Descrição da oferta de emprego

Genomics plc in London (Hybrid) seeks a Staff-level data platform engineer to own Mystra’s data foundations and our Data-as-a-Service offering. You’ll shape multi-tenant analytics, drive secure, scalable architecture, and mentor engineers while collaborating with the ML team.

Responsibilities include designing resilient storage and release strategies, ensuring data products are discoverable at scale, and enabling agent-ready AI capabilities for drug discovery.